Main Session
Sep
30
QP 18 - Radiation and Cancer Biology 5: Cellular Radiation Effects & DNA damage response
1103 - SETD2 Loss Predicts Response to Chemoradiotherapy in Rectal Cancer: Clinical Outcomes and Preclinical Validation in Orthotopic Models
Presenter(s)
Romy Megahed, MD - UAMS Radiation Oncology, Little Rock, AR